Given the pivotal role of bifidobacteria and LAB in improving/maintaining health, coupled with the acute rise in antimicrobial resistance (AMR) among pathogenic bacteria, there is an increasing trend in the probiotic market for new target strains with more efficient probiotic potential, antimicrobial activity [but lack of AMR genes (ARG)] and immunomodulatory anti-infection capacities.
← all excerpts
Genomic insights into the beneficial potential of <i>Bifidobacterium</i> and <i>Enterococcus</i> strains isolated from Cameroonian infants.
1
—
—